申请人:XENIOPRO GMBH
公开号:US20200031763A1
公开(公告)日:2020-01-30
The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the hematopoietic system including the hematologic system in human and veterinary medicine.